Sui Li-hua

975 total citations · 1 hit paper
24 papers, 812 citations indexed

About

Sui Li-hua is a scholar working on Molecular Biology, Materials Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Sui Li-hua has authored 24 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Materials Chemistry and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Sui Li-hua's work include Advanced Nanomaterials in Catalysis (4 papers), RNA Interference and Gene Delivery (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Sui Li-hua is often cited by papers focused on Advanced Nanomaterials in Catalysis (4 papers), RNA Interference and Gene Delivery (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Sui Li-hua collaborates with scholars based in China and United States. Sui Li-hua's co-authors include Kelong Ai, Yayun Nan, Qiong Huang, Tianjiao Zhao, Wei Wu, Jianhua Liu, Zhi‐Chun Yang, Zuoxiu Xiao, Liyuan Guo and Jian-Ling Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Gynecologic Oncology.

In The Last Decade

Sui Li-hua

21 papers receiving 802 citations

Hit Papers

Reactive oxygen species-based nanomaterials for the treat... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Sui Li-hua
Comparison fields: 5 of 100
  • Molecular Biology 357
  • Biomedical Engineering 251
  • Materials Chemistry 196
  • Biomaterials 105
  • Oncology 78
Replace Wangshu Zhu with:
Wangshu Zhu China
Ankush Sharma United States
Zheng Pan China
Yajuan Yang China
Pan Zhou China
Shiping Ding China
Han Cui China
Zhaowei Chen China
Balsam Rizeq Qatar
Chao Jia China
Wangshu Zhu China View profile →
Citations per field, relative to Sui Li-hua
Sui Li-hua · 1×
Citations per year, relative to Sui Li-hua
Sui Li-hua · 1×

Countries citing papers authored by Sui Li-hua

Since Specialization
Citations

This map shows the geographic impact of Sui Li-hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui Li-hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui Li-hua more than expected).

Fields of papers citing papers by Sui Li-hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sui Li-hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui Li-hua. The network helps show where Sui Li-hua may publish in the future.

Co-authorship network of co-authors of Sui Li-hua

This figure shows the co-authorship network connecting the top 25 collaborators of Sui Li-hua. A scholar is included among the top collaborators of Sui Li-hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui Li-hua. Sui Li-hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 6
3 71
4
Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries breakdown →
225
5 184
6 2
7 74
8 26
9 3
10 23
11 32
12 74
13 18
14
Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.
39
15
[Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
2
16
[Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
0
17 1
18
[Study on the relationship between genesis and development of cervical cancer and the infection of human papillomavirus type 16/18, human herpesvirus II and cytomegalovirus].
3
19
[Experimental therapy of survivin antisense oligonucleotide for human ovarian cancer cell SKOV3].
2
20
Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells.
11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026